Fed Circuit dismisses West-Ward appeal in Novartis suit

15-05-2019

Fed Circuit dismisses West-Ward appeal in Novartis suit

Lucarista / Shutterstock.com

The Federal Circuit has ruled that a Novartis patent is valid despite an error of reasoning from a district court.


Federal Circuit, US Court of Appeals for the Federal Circuit, West-Ward Pharmaceuticals, Novartis, everolimus, renal cell carcinoma, kidney cancer, patent

More on this story

Double victory for Novartis at Federal Circuit
10-12-2018

LSIPR